drugset

drugset / Trial / NCT05518422

Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity

NCT05518422 ↗

Phase 0 Withdrawn University of Missouri-Columbia

NaSingle-groupOpen-labelBasic science

Summary

The aim of this project is to determine role for ET-1 in individuals with obesity.

Timeline

Start: 2024-02
Primary completion: 2024-02
Completion: 2024-02

Outcome

Outcome not reported

Stopped (Enrollment): “No participants enrolled”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bosentan	Other / unclassified	—	Oral

Indications